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Foot-and-mouthdisease(FMD)isoneofthehighlycontagiousdiseasesofdomesticanimals.Eﬀectivecontrolofthisdiseaseneeds
sensitive, speciﬁc, and quick diagnostic tools at each tier of control strategy. In this paper we have outlined various diagnostic
approaches from old to new generation in a nutshell. Presently FMD diagnosis is being carried out using techniques such as
Virus Isolation (VI), Sandwich-ELISA (S-ELISA), Liquid-Phase Blocking ELISA (LPBE), Multiplex-PCR (m-PCR), and indirect
ELISA (DIVA), and real time-PCR can be used for detection of antibody against nonstructural proteins. Nucleotide sequencing for
serotyping,microarrayaswellasrecombinantantigen-baseddetection,biosensor,phagedisplay,andnucleic-acid-baseddiagnostic
are on the way for rapid and speciﬁc detection of FMDV. Various pen side tests, namely, lateral ﬂow, RT-LAMP, Immunostrip tests,
and so forth. are also developed for detection of the virus in ﬁeld condition.
1.Introduction
Foot-and-mouth disease (FMD) is a highly contagious
disease aﬀecting artiodactylae, mostly cattle, swine, sheep,
goats, and many species of wild ungulates [1]. FMD aﬀects
extensive areas worldwide and is included in the list of dis-
easesnotiﬁabletotheWorldOrganizationforAnimalHealth
(http://www.oie.int/eng/en index.htm). It is recognized as a
signiﬁcant epidemic disease threatening the cattle industry
since the sixteenth century and till date it is a major global
animal health problem. The history of FMD may be traced
to era of Hieronymus Fracastorius, a monk who described
a disease outbreak in 1546 A.D. that occurred in cattle near
Verona, Italy [2]. Almost 400 years later, in 1897, Friedrich
Loeﬄer and Paul Frosch demonstrated that a ﬁlterable agent
is responsible for FMD [3]. This was the ﬁrst demonstration
that a disease of animal was caused by a ﬁlterable agent and
ushered in the era of virology.
FMD generally involves mortality rates below 5%, but
even so it is considered the most important disease of farm
animals since it causes huge losses in terms of livestock
productivity and trade. Although FMDV rarely causes death
in adult animals, the virus can cause severe lesion in the
myocardium of young animals, leading to high mortality
rates [4–6]. The main constraints in controlling this disease
and why it is considered as the most dreaded viral disease
are its high contagiousness, wide geographical distribution,
broad host range, ability to establish carrier status, antigenic
diversityleadingtopoorcross-immunity,andrelativelyshort
duration of immunity. Poor surveillance and diagnostic
facilities as well as inadequate control programs are major
problems in control of this disease in the country. FMD
is still a leading cause of loss of livestock economy in
India. Outbreaks are still being reported from time to time
around the year [7]. Besides causing direct losses to livestock
economy it also causes indirect losses in terms of severe trade
restrictions, impact which may be higher than direct losses.
The etiological agent, foot-and-mouth disease virus
(FMDV) is classiﬁed within the genus Aphthovirus in the
family Picornaviridae [8]. The virus exists in the form of2 Veterinary Medicine International
seven serologically and genetically distinguishable types,
n a m e l y ,O ,A ,C ,A s i a 1 ,S A T 1 ,S A T 2 ,a n dS A T 3 ,b u tal a r g e
number of subtypes have evolved within each serotype [9].
Serotype O and A reported in France by Valee and Caree
[10] and in 1926, Waldmann and Trautwein [11]r e p o r t e d
serotype C. Serotypes SAT1, SAT2, and SAT3 of FMDV was
observed in sample collected from the FMD outbreak in
South Africa. The seventh serotype, Asia 1, was reported
from Pakistan [12].
FMDV is a single stranded (ss) positive sense RNA
virus with the whole virus particles having sedimentation
coeﬃcient of 146S [13] and genome of ∼8.5Kb size. The
genome is polyadenylated at 3  end and carries a small
covalently linked protein, VPg at 5  end [13]. The 5 
untranslated region (UTR) contains a short fragment called
S-fragment,apoly(C)tractfollowedbylarge(L)fragmentof
over 700 bases. Functionally, the genome can be categorized
into three main regions: (a) 5  noncoding regulatory region,
(b) polyprotein coding region (subdivided into L, P1, P2,
and P3), and (c) 3  noncoding regulatory region. The
translation initiation starts at two AUG codons separated
by 84 nucleotides following the Internal Ribosome Entry
Site (IRES). The viral genome is translated as a single
polyprotein, which is posttranslationally cleaved by viral
proteases [14] into four structural proteins (VP1, VP2, VP3,
and VP4) and several nonstructural proteins (L, 2A, 2B, 2C,
3A, 3B, 3C, and 3D) [15] .T h eP 1r e g i o no fg e n o m ee n c o d e s
the 4 structural proteins VP1, VP2, VP3, and VP4 encoded
by 1D, 1B, 1C and 1A genomic regions, respectively, [13].
Sixty copies of each structural protein (VPl-4) assemble to
form the capsid [13]. Among which VP4 is internal whereas
others are exposed on virion surface [16]. The 3 surface
exposed capsid proteins carry the neutralizing antigenic sites
[17]. Among the 4 structural polypeptides, VP1 is the most
immunogenic protein of FMDV [18] having its G-H loop
protruded from the surface [19], and is maximally exposed
on the capsid surface [16, 20]f o r m i n gl a r g ep a r t( 5 4 % )o f
virus surface [21].
Although, the disease has been controlled successfully in
many parts of the world by regular vaccination of susceptible
animals and slaughtering of infected animals, no country
has been considered safe, because of the highly contagious
nature and rapid spread of the infection [22]. For the
eﬀective control of the disease, outbreaks should be detected
at an early stage and persistent infections should also be
recognized to prevent further transmittance. These can be
achieved when vaccination is regular and eﬀective and when
diagnostic tools available are speciﬁc and sensitive and at the
sametime rapid.
Lots of work has been carried out to develop and validate
diagnostic tests in regard to this disease. Conventional
t e c h n i q u e ss u c ha sc o m p l e m e n tﬁ x a t i o nt e s t( C F T )[ 23],
serum neutralization tests (SNT) [24] and enzyme-linked
immunosorbent assay (ELISA) [25] are still in use for the
routine detection of FMDV in clinical samples. Sandwich
ELISA is being carried out for the detection of speciﬁc
FMDV antigens in epithelial tissue suspensions which is
usually accompanied by concurrent cell culture isolation
and the application of ELISA to any samples showing
a cytopathogenic eﬀect [26]. Virus isolation in primary
cultures is laborious, expensive, and requires days/weeks
(cell passages) before the results are obtained [27]. However,
with the introduction of molecular techniques in the ﬁeld
of diagnosis, several techniques based on viral genome
detection such as hybridization using DNA probes [28]a n d
the advent of Polymerase Chain Reaction (PCR) technique
in the recent past have led to development of several
reverse transcription PCR (RT-PCR) procedures for speciﬁc
detection of FMDV RNA [29–34]. Because of the reported
sensitivity and speciﬁcity, RT-PCR has been evaluated as a
diagnostic tool for FMDV detection in parallel with ELISA
and virus isolation [35]. Another form of PCR, multiplex
PCR (mPCR), has also been evaluated for diﬀerentiating
FMDV serotypes [27, 36, 37]a sw e l la sf o rd i ﬀerential
diagnosis with other vesicular diseases such as Vesicular’
Stomatitis, Swine Vesicular Disease [38]. The most recent
development in the ﬁeld of diagnosis by nucleic acid
detection is the use of thermal cyclers capable of measuring
ﬂuorogenic PCR ampliﬁcation in real-time have become
available, making precise quantitation of nucleic acids pos-
sible over a wide concentration range. The ﬂuorogenic RT-
PCR provides relatively fast result, enables a quantitative
assessmenttobemadeofvirusamount,andcanhandlemore
samplesand/orreplicatesofsamplesinasingleassaythanthe
conventional RT-PCR procedure [39].Ther efor eitisseenasa
valuabletooltocomplementtheroutinediagnosisprocedure
for FMD virus diagnosis.
Currently, the FMD diagnosis in our country (India)
is being carried out using techniques developed at Project
Directorate on FMD (PD FMD), Mukteswar which includes
Virus isolation (VI), Sandwich-ELISA (S-ELISA), Liquid-
Phase Blocking ELISA (LPBE), Multiplex-PCR (mPCR) and
recently DIVA test which is an indirect ELISA for detection
of antibody against nonstructural proteins. LPBE is being
used for the detection of antibody titers against the FMD
vaccinated animals. The S-ELISA is being used for the
antigen detection using the material from the lesions but
because of its low sensitivity currently mPCR is being used.
The real-time PCR-based detection method is used in the
many reference laboratories in the world for the purpose [7].
2. Etiology andMolecularOrganisationof
the Virus
Foot-and-mouth disease virus (FMDV) was the ﬁrst recog-
nizedviralpathogen[40]andisthesolememberofthegenus
Aphthovirus belonging to the Picornaviridae family. Seven
immunologically diﬀerent serotypes of the FMD virus are
known, namely, A, O, C, Asia-1, South-African Territories
(SAT) -1, -2 and -3, which comprise more than 65 subtypes.
Initially 2 types were named: type O for Oise in France
and type A for Allemagne (Germany) [10]. Later type C
was recognized as an additional type in Germany [11].
Some 30 years later, work at Pirbright laboratory in England
demonstrated3novelserotypesofFMDVinsamplecollected
from the FMD outbreak in South Africa and called SAT1,
SAT2, and SAT3. The seventh serotype, that is, Asia 1 was
ﬁrst recognized in a sample from Pakistan [12].Veterinary Medicine International 3
The viral particle, or virion, contains a single-stranded
RNA of positive polarity, approximately 8500 nucleotides
long. It is an icosahedral particle with a smooth surface
and a diameter of about 30nm [13]. The ﬁne structure
of the virus has been described by X-ray crystallography
[16, 41, 42]. There are 60 copies of each of the structural
protein VP1, VP2, VP3, and VP4. While the ﬁrst three
structural proteins (MW≈24 kDa) have surface compo-
nents, the fourth (MW≈8.5kDa) is internal. The virion
is also usually composed of one or two units of VP0,
the precursor of VP2 and VP4 [16, 43]. The structural
proteins, VP1-3 fold into an eight-stranded wedge-shaped
13-barrel which ﬁts together to form the majority of the
capsid structure [16]. The three-dimensional structure of
FMDV has revealed a prominent surface feature formed
by the loop between the G and H strands of VP1.
The VP4 protein is located inside the capsid [44]. The
strands of the 13-barrel of VP1-3 are connected by loops
which form the outer surface of the virion [45]. Unlike
other picornaviruses, FMDV lacks a surface canyon or
pit which is the receptor binding site for entero- and
cardioviruses [46]. Another feature of the virion is the
channel at the ﬁvefold axis which permits the entry of small
molecules such as Cscl into the capsid resulting in FMDV
having the highest buoyant density of the picornaviruses
[42].
The main cell attachment site and the immunodominant
regionofFMDVarebothlocatedonasolventexposedregion
at the surface of the virion, namely, in trypsin-sensitive
areas of VP1 [47, 48]. Earlier serological studies showed that
diﬀerent serotypes of FMDV shared a highly variable region
of VP1, comprising residues 135 to 155 [49], as one of the
major antigenic sites of the virus.
The genome of FMDV is about 8.5Kb in length enclosed
within a protein capsid. It has four major parts: 5  Untrans-
lated region (5 UTR), Coding region, 3  Untranslated region
(3 UTR), and a poly “A” tail. The 5 UTR is linked with
Vpg (3B) which serves as primer in replication. 5 UTR
contains an S fragment at its 5  end which encompasses
360 bases, folds into long stem loop and plays a role in
genome stability and the binding of protein involved in
genome replication [50]. Following S fragment there is
poly “C” tract comprising over 90% “C” residues. The
length of this tract is extremely variable [51]. There are
some evidences that length of this tract is associated with
virulence and hence persistence [52]. After poly “C” tract,
there is a series of RNA pseudo knot structures of unknown
function [53]. Downstream to the pseudo knot there is cis-
acting replicative element (cre) [54] .T h ec r eh a sc o n s e r v e d
AAA sequences and is essential for genome replication
[54]. Downstream to cre is internal ribosomal entering sites
(IRES). The IRES has role in initiation of viral protein
synthesis and shutting down of host cell protein synthesis
[53]. Due to the presence of IRES, picornaviruses are able
to bind to ribosomes to initiate the protein synthesis.The
picornaviruses have no 5 cap (7-methyguanosine), so IRES
serves as ribosomal entering site [55]. The 3 UTR follows the
ORF (open reading frame) termination codon and contains
a short stretch of RNA which folds into speciﬁc stem loop
structures [56] followed by a poly “A” tract of variable length
[57]. This 3 UTR also serves as some functions in genome
replication[58].3 UTRisspeciﬁcforeachpicornavirus.Poly
“A” probably plays a role in FMDV translation [59]a n d
replication [60]. The FMDV genome encodes a polyprotein
from which four diﬀerent structural and eight diﬀerent
non-structural proteins are formed by the viral proteases.
After translation, the four primary cleavage products are
formed: (i) the amino terminal L protease which cleaves at
its own carboxy terminus, P1- 2A, (ii) the precursor of the
capsid proteins (iii) 2BC, and (iv) P3 which is cleaved to
make the NSPs [61]. FMDV has two proteinases. The NSP
leader proteinses (Lpro) located in the N-terminal region
of the polyprotein acts both intra and intermolecularly.
This protease initiates cleavage by separating itself from
P1, the precursor of the capsid protein and the remainder
of the growing polypeptide chain [62]. The 3C protease
is responsible for the cleavage of P1 into 1AB (VP0), 1C
(VP3),and1D(VP1).The1A/1B(VP4/VP2)cleavageoccurs
at the late stage in virus morphogenesis and is associated
with maturation of capsid. The 2C/3A primary cleavage is
cis and subsequent cleavage is also mediated by the 3Cpro
andproducingprocessingintermediatesandmatureproteins
[63].Inadditiontoviralproteinprocessing,the3Cprocleave
thehostcellproteinhistoneH3andmaybeinvolvedwiththe
shuting down of host cell transcription [64]. The cleavage
between 2A/2B junctions is mediated by 2A polypeptide
separating itself and P1 away from 2BC/P3 [61]. This change
is independent of both L and 3C. The FMDV 2A region is
very short (about 18 amino acids) and together with the N-
terminal residues of protein 2B, represents an autonomous
element capable of mediating cleavage at its own C terminus
[65].
3. Epidemiology of the Disease
FMD is a highly transmissible disease, and a limited number
ofinfectiveparticlescaninitiatehostinfection[66].Contam-
inated animal products, nonsusceptible animals, agricultural
tools, people, vehicles, and airborne transmission [67]c a n
contribute to the mechanical dissemination of FMDV. The
epidemiology of FMD is complex, and it is aﬀected by
diﬀerentviral,host,andenvironmentalfactors,amongthem,
variations in virus virulence (severity of lesions, amount,
and duration of virus release), particle stability in diﬀerent
microenvironments, and chances of long-term persistence.
FMDV multiplication and spread also depend on the host
species, nutritional and immunological status, population
density, animal movements, and contacts between diﬀerent
domestic and wild host species and animals capable of
mechanical dissemination of the virus [68]. The environ-
ment can provide geographical barriers to virus dissem-
ination or, alternatively, can promote virus transmission
when appropriate atmospheric conditions prevail. In this
multifactorialscenario[69,70],thehighpotentialforFMDV
variationandadaptationhasmodelledcomplexevolutionary
patterns that are being revealed by molecular epidemiology
analyses, mostly based on nucleotide sequencing of capsid
protein genes.4 Veterinary Medicine International
Of the diﬀerent serotypes prevalent in India, type “O”
has been found to be predominant over other types [71–
77]. Similarly in the North-Eastern region of India, the
frequency of FMD is highest with type “O”, which is
always followed by other types including the type “Asia-1”
[78, 79]. The agroclimatic and socioeconomic condition,
mixed animal husbandry practices, unrestricted movement,
and trade among animals and porous international border
provide a conductive epidemiology niche for the FMDV to
ﬂourish, mutate, and persist over time and to aﬀect the
susceptible animal population [80, 81].There are records of
about 5,000 outbreaks to occur in India annually aﬀecting
nearly three lakh animals [82] with an estimated staggering
loss of Rs. 4,300 cores to the economy annually [83].The
losses are mainly due to reduction in milk yield, draught
power, and breeding capabilities. In India where world’s
largest livestock populations exist, it is a leading cause of loss
of livestock economy (direct and indirect losses) due to its
endemic nature.
4. Pathological Aspectof FMD
Foot-and-mouth disease (FMD) is an acute systemic infec-
tion aﬀecting even-toed ungulates, both domesticated and
wild, including cattle, swine, sheep, and goats. Beside
domesticated animals, other animals species aﬀected with
FMD includes elephant [84], mithun [85, 86], yak [87],
sambar, spotted deer, and wild buﬀalo [87, 88].
FMDV produces an acute, systemic vesicular disease,
which requires a diﬀerential diagnosis from other vesicular
diseases [89]. In natural infection, the main route of virus
entry is the respiratory tract. The initial virus multiplication
usually takes place in the pharynx epithelium, producing
primary vesicles, or “aphthae” [90] .T h ev e s i c l e sp r o d u c e d
by FMDV generally aﬀect cells from the epithelial stratum
espinosum. The clinical outcome of the disease may vary
among the host species considered and the infecting virus
strain. In cattle and pigs, fever and viraemia usually start
within 24–48 hr after epithelium infection, leading to viral
spread into diﬀe r e n to r g a n sa n dt i s s u e sa n dt h ep r o d u c t i o n
of secondary vesicles preferentially in the mouth and feet.
The acute phase of disease lasts about 1 week and declines
graduallycoincidingwiththeemergenceofastronghumoral
response [91].The morbidity and mortality in FMD depends
upon the breed and age of the animal where mortality in
adult animals is very low (two per cent) in comparison to
20 per cent in young stock [92]. The calves show prominent
signs of myocarditis, whereas piglets manifest gastroenteritis
[93]. In sheep and goats, symptoms are frequently less severe
and may make the detection of the disease diﬃcult [94].
Asymptomatic, persistent infection can also be estab-
lished in ruminants, during which infectious virus can be
isolatedfromtheoesophagusandthroatﬂuidsoftheanimals
from a few weeks up to several years of the initial infection.
There is epidemiological evidence to support the hypothesis
that carrier animals may be the origin of outbreaks of
acute disease when brought into contact with susceptible
animals. This mode of transmission has been experimentally
reproduced for serotype SAT isolates [95].
5.DiagnosisofFMD
The accurate diagnosis of infection with FMDV is of
prime most importance for both control and eradication
campaigns in FMD endemic areas and as a supportive
measure to the stamping out policy in FMD-free areas [96].
The history of research and diagnosis in foot-and-mouth
disease falls into several distinct areas. The search for experi-
mentallaboratoryanimals,producingthediseaseculminated
in the demonstration by Waldmann and Pape [97], the
susceptibility of the guinea pig, and the suckling mouse by
Skinner in 1951. Early work by Hecke and the Maitlands in
the early 1930s, followed by the crucial demonstration by
Frenkel in 1947 that large amounts of the virus could be
produced in surviving tongue epithelium, formed the basis
for the vaccination programmes initiated in Europe in the
1950s [98]. The subsequent development of cell lines has
brought a remarkable degree of sophistication to the study of
virus growth. The recognition of more than one serotype has
led to the development of various techniques for serotyping
of the virus. As early as 1927, Bedson et al. found that two
isolates of a serotype “A” virus could be diﬀerentiated by
cross-neutralization tests [99]. Earlier typing of FMDV was
done by cross-immunity test in guinea pigs [11] and less
frequently in cattle [13]. As this test was time consuming,
expensive, and imprecise [100], diﬀerent serological tests like
complement ﬁxation test (CFT), virus neutralization test
(VNT), and enzyme-linked immunosorbent assay (ELISA)
were developed and the most recent is the development of
molecular techniques, the polymerase chain reaction (PCR)
method making diagnosis more rapid and precise. Presently
wehavedemonstratedthatmultiplex PCRcoulddetectFMD
virus in the highest number of samples (65.47%) followed
by sandwich ELISA (53.57%) and virus isolation (42.85%)
[101].
5.1. Complement Fixation Test (CFT). In 1929, Ciuca was
ﬁrst to use CFT for typing antiserum and FMDV of
guinea pig origin [13]. Later, virus of bovine origin was
successfully typed by CFT using guinea pig antiserum [23].
Since then CFT has been used extensively for distinguishing
diﬀerent strains of FMDV [24, 102, 103]. Subsequently, a
modiﬁcation of CFT, micro-CFT was developed, in which 96
well microtiter plates were used instead of tubes [104]. In the
years1964-1965 CFT(tubetest)wasusedtoreplacethevirus
type identiﬁcation by guinea pig cross-protection test [105].
Subsequently, the micro-CFT was adopted for this purpose
[106, 107]. Although CFT was a fast method it needed high
virus load and results were sometimes aﬀected by pro-and
anticomplementary activities of the test sample [26].
5.2. Virus Isolation. Primary cell culture of bovine [108–
110], ovine and porcine [111]o r i g i nh a se x h i b i t e ds u s -
ceptibility to FMDV from infected tissues. However, the
most sensitive culture system for virus isolation is primary
bovine thyroid cells [109] but cryopreservation of bovine
thyroid cells directly after trypsinization results in the loss
of susceptibility to FMDV [110]. Some stable cell lines, like
IBRS-2[112],MVPK-1clone7[112,113],LFBKcelllineandVeterinary Medicine International 5
BHK-21 [114] are also susceptible to FMDV and so are most
desirable for diagnostic system but these are less sensitive
than primary cells for detecting low amount of infectivity
[115].
Revenson and Segura [116] reported that FMDV grew
well on BHK-21 cell line enabling large-scale production of
antigen with good complement ﬁxing properties. The BHK-
21 cell culture provides better growth for FMDV than the
suspension culture [115, 117, 118]. It has also been reported
that with subsequent passage in BHK-21 clone 13 cell line,
the titre of FMDV increased signiﬁcantly [108]. Nair [112]
reported that the susceptibility and infectivity titers of IBRS-
2 and MVPK cell lines were less as compared to BHK-21
cells, and thus had no advantage over BHK-21 cell line for
vaccine production. Mishra et al. [119] also adapted FMDV
ﬁeld isolates to BHK-21 clone 13 cells in 3-7 serial passage.
Goel and Rai [120] reported that the ﬁeld isolates of
FMDV could be passaged in BHK21 clone 13 monolayer cell
culture, which showed characteristic CPE and were readily
adapted between 3rd and 5th passage. The CPE usually
develops within 48 hours, if no CPE is detected the cells
shouldbefrozenandthawed,usedtoinoculatefreshcultures
and examined for CPE for another 48 hours. An alternative
to the virus isolation is cell suspension plaque test which also
quantify the virus present in sample [121]. However, the cell
culture system is laborious, time consuming, and relatively
low sensitive. It also requires careful handling of specimens
and a biosafety laboratory.
The availability of cell culture techniques and the realiza-
tion that FMDV can be grown in in vitro cultured cells made
possible the adaption of neutralization test for routine type
identiﬁcation of FMDV isolates and were found to be more
speciﬁcthanCFT[100].Inparticular,virusisolationrequires
a laboratory cell culture facility, which can be diﬃcult and
expensive to maintain, besides requiring 4 to 6 days for
test completion [122]. Subsequently microneutralization test
(MNT) was used for the assessment of antigenic variation in
ﬁeld strains, as it correlated well with cattle protection test
[123, 124]. But it was observed that, minimal heterotypic
contamination in the sample could interfere with precise
type identiﬁcation of the virus [24]; on the other hand VN
testdependsontissuecultureandismorepronetovariability
than ELISA and also require biocontainment facilities.
5.3. Enzyme-Linked Immunosorbent Assay (ELISA). ELISA
came into use as diagnostic methods for many infectious
diseases around the year 1975; till then it has been used
as one of the most accepted serological techniques. The
ﬁrst report of use of an indirect ELISA to screen cattle
for antibodies against FMDV was that of Abu Elzein and
Crowther [125]. Subsequently, a sandwich ELISA using
convalescent bovine immunoglobulin (Igs) as capture and
anti-146S guinea pig sera as tracing sera was found suit-
able for detection and quantiﬁcation of FMD virus in
infected tissue culture ﬂuid and epithelial tissue samples
[126]. The use of anti-146S rabbit immunoglobulin in
place of convalescent bovine immunoglobulin as cap-
ture antibody increased the sensitivity of sandwich ELISA
[127].
L a t e rE L I S Aa n di t sv a r i o u sm o d i ﬁ c a t i o n sw e r ea p p l i e d
for detection, typing, and strain diﬀerentiation of FMDV
isolates with better sensitivity than CFT and, the results were
comparable to that obtained with MNT [25, 125, 128–134].
Liquid phase blocking ELISA using bovine convalescent sera
for characterization of ﬁeld isolates was done and result
talliedwithconventionalVNT[135–137].ELISAresultswere
much more reproducible than those obtained with VNT and
are not inﬂuenced by variations in tissue culture susceptibil-
ity. At the FAO/WRL for FMD, the preferred procedure for
the detection of FMDV antigen and identiﬁcation of viral
serotypes is ELISA [26, 138]. The results can be obtained
within 3-4 hours after sample is received by the laboratory;
a negative sample is conﬁrmed by inoculation of sample
into sensitive cultures followed by conﬁrmation of the virus
serotype by ELISA. Indirect ELISA was initially used for
detectionofFMDVantigenininfectedcellcultureﬂuid,mice
carcass,andcattletongueaswellasantibodiesinserasamples
[129, 133]. Later a sandwich ELISA was used for subtype
analysis of FMDV isolates [134]. Subsequently, a sandwich
ELISA was developed for detection and typing of FMDV
directly from ﬁeld materials [139]. Although ELISA is far
ﬁner to CFT, a large number of samples failed to give positive
results and such negative sample has to be conﬁrmed by
inoculation of sample into sensitive cultures [140] followed
by conﬁrmation of the virus serotype by ELISA taking 4
more days, a time frame compatible with the need to rapidly
detect disease and initiate and appropriate disease control
strategy. As a consequence, there is a need of an alternative
assay system that allows more rapid conﬁrmation of clinical
diagnosis with more sensitivity and this has resulted in
development of polymerase chain reaction (PCR) or the
more recent real-time PCR.
5.4. Reverse Transcription-Polymerase Chain Reaction (RT-
PCR). Polymerase chain reaction was the most widely use
nucleic-acid-based diagnostic techniques since its invention
[141, 142]. With the development of RT-PCR to amplify
RNA targets many workers have assessed the usefulness of
it as a reliable tool for FMD diagnosis [29, 30, 32, 33]
and in parallel with conventional assays [34, 143, 144]. A
particularly high sensitivity was reported by RT-PCR ELISA
[143, 145]. A speciﬁc RT-PCR was developed and validated
for the detection of the polymerase gene (3D) of FMD with
an analytical sensitivity equal to 1000 times higher than
that of a single passage virus isolation [146]. In a study to
compare the sensitivity of assays for the diagnosis of FMD, a
cell suspension plaque test on BHK21-CT cells and a reverse
transcription nested PCR (RT-nPCR) were used to examine
nasal swabs and probang samples obtained from FMDV
infectedcattle,ithasbeenobservedthatexaminationofnasal
swab revealed a higher number of infected animals using RT-
nPCR than by the used the plaque tests and for probang
samples both test gave approximately equivalent result [147].
PCR products generated have currently only been analyzed
by gel electrophoresis exposing to the chance of post-PCR
contamination. However PCR oﬀers potential advantages
over other conventional tests. The risk of false negative
associated with poor sample handling is limited. Because6 Veterinary Medicine International
virus, if present, would be inactivated by RNA extraction,
it would be acceptable to use lower level biosafety. Further,
cell culture loses the sensitivity due to presence of inhibitors
like interferons and presence of some enzymatic inhibitors.
Several studies have compared Reverse Transcription (RT-
PCR)methodswithFMDVisolation[35,143,147–149].The
sensitivity of the methods reach similar to or greater than
virus isolation techniques and these can supplement or go in
parallel,butnotreplace,theroutineproceduresfordiagnosis
of FMDV. Detection of all seven serotypes of the virus
with each of the serotype speciﬁc primers in selected RT-
PCR protocols at OIE/FAO World Reference Laboratory for
FMD(WRL),Pirbrightdemonstratedsuitablespeciﬁcityand
detected cell culture passage isolate with some success but
were not adequate for the serotyping of suspension prepared
from clinical samples of epithelium. RT-PCR though has
paved the way to more sensitive and rapid test in the ﬁeld
of molecular diagnosis, serotyping of FMDV has been of
diﬃcultandthishasbeensolvedwiththeadventofmultiplex
PCR (mPCR).
5.5. Multiplex Polymerase Chain Reaction (mPCR). To over-
come the inherent disadvantage of cost and to improve the
diagnostic capacity of the test, multiplex PCR, a variant of
the test in which more than one target sequence is ampliﬁed
using more than one pair of primers, has been devel-
oped. This modiﬁed technique was originally developed to
detect distinct/genetic alterations in large regions of human
genome. Afterwards, mPCR was used for the detection and
diﬀerentiation of multiple pathogens/diﬀerent strains of the
same pathogen. It has additional advantages such as cost-
eﬀectiveness and rapidity. There are reports on the use of
mPCR for diﬀerential diagnosis of FMDV serotypes [27, 36].
One such PCR [36] was evaluated in WRL FMD Pirbright
and found to work on tissue samples with limited success
[148]. To improve the overall diagnostic sensitivity and to
provide tools for serotyping FMDV, multiplex PCR arrays
have been developed to detect FMDV in infected tissue and
food samples [150].
TheconceptofusingmultiplexPCRtodetectFMDVand
its serotypes has also been examined by others [151, 152]. An
advantage of multiplex PCR systems, compared with probe-
based assays, is that the intrinsic design does not rely on a
probe for a single conserved gene or region of the genome.
Rather, the multiplex system is designed to survey multiple
regions of the genome simultaneously, thereby increasing
the probability of detection [153]. To date, these mPCR
assays are limited to partial serotyping of FMDV because
no existing multiplex PCR assay oﬀer complete coverage
for all seven serotypes [154]. Multiplex PCR for diﬀeren-
tial diagnosis of various vesicular diseases like Vesicular
Stomatitis, Swine Vesicular Disease, Vesicular Exanthema,
and FMDV have also been described [38, 155]. Recently,
mPCR for diﬀerentiation of Indian FMDV serotypes has
been developed and evaluated on tongue epithelium and cell
culture samples [37]. In the earlier studies, we have showed
that multiplex PCR are more sensitive than sandwich ELISA
and virus isolation for detection of FMDV from clinical
materials [101].
5.6. Real-Time Polymerase Chain Reaction. The use of poly-
merase chain reaction (PCR) in molecular diagnostics has
increased to the point where it is now accepted as the gold
standard for detecting nucleic acids from a number of origin
and it has become an essential tool in the research laboratory
[156]. The potential of this format to provide sensitive,
speciﬁc, and swift detection and quantiﬁcation of viral
RNAs has made it an indispensible tool for state-of-the-art
diagnostics of important human and animal viral pathogens
[157]. Real-time PCR has engendered wider acceptance of
PCR due to its improved rapidity and sensitivity [156]
overcoming poor precision, low sensitivity, low resolution,
absence of automation, only size-based discrimination,
absence of expression of results in numbers, poor quanti-
tative performance (Ethidium bromide for staining is not
very quantitative), and post-PCR processing, rendering the
conventional PCR not very suitable for accurate diagnosis.
There are currently ﬁve main chemistries used for the
detection of PCR product during real-time PCR. These
are the DNA-binding ﬂuorophores, the 5  endonuclease,
adjacent linear and hairpin oligoprobes, and the self-
ﬂuorescing amplicons [156]. This approach is a highly
sensitive technique enabling simultaneous ampliﬁcation and
quantiﬁcation of speciﬁc nucleic acid sequences. In addition
to enhanced sensitivity, the beneﬁts of real-time PCR assays
over conventional endpoint detection methods include their
large dynamic range, a reduced risk of cross-contamination,
an ability to be scaled up for high-throughput applications
and the potential for accurate target quantiﬁcation [158–
160]. Real-time PCR assays recommended by the World
Organizationforanimalhealth(OIE)fordetectionofFMDV
incorporateuniversalprimersandﬂuorescent-labeledprobes
that recognized conserved region within the 5  UTR [39]
or conserved gene regions within the RNA-dependent RNA
polymerase gene (3Dpol) [161]. The use of a speciﬁc probe
facilitatesanincreaseinspeciﬁcitycomparedtoconventional
agarose-gel-based PCR assays [162, 163].
Recently,TaqMantechnologyhascombinedthe5  nucle-
aseactivityoftheTaqDNApolymeraseandforsterresonance
energy transfer to detect and quantify ampliﬁcation product
in a closed tube format. Using this technology real-time PCR
has been developed to detect the nucleic acid [164, 165].
This is most sensitive and rapid method to detect the nucleic
acid. The viral RNA can be consistently detected over a seven
log range, the lowest of which corresponded to as few as
10–100 RNA per volume tested. The test can be performed
in 2 hours or less on a portable instrument and sample
can be held at ambient temperatures. Real-Time chemistry
allows for the detection of PCR ampliﬁcation during the
early phases of the reaction and as the name suggest, real-
time PCR monitors the progress of a PCR reaction in the
real-time. At the same time, a relatively small amount of
PCR products (DNA, CDNA, or RNA) can be quantiﬁed.
Measuring the kinetics of the reaction in the early phases
of PCR provides a distinct advantage over traditional PCR
detection. Traditional methods use agarose gels for detection
of PCR ampliﬁcation at the ﬁnal phase or end point of the
PCR reaction which is associated with considerable hands
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carryover, and limits the number of specimen that can be
processed simultaneously. It is hard to diﬀerentiate the 5 fold
changes on gel whereas real-time PCR is able to detect even
twofold changes (e.g., 10 versus 20 copies). In addition to the
widely exploited 5 -nuclease (TaqMan) system using dual-
labelled probes [39, 161, 166] and modiﬁed MGB probes
[167], assays have also been developed using other rRT-PCR
formats such as those using hybridization probes [146]a n d
PriProET [168].
The greatest problem facing the diagnostic application
of PCR is the production of false positive results. They are
attributable to contamination by nucleic acids, particularly
from the previously ampliﬁed material (carry over). Any
contaminant, even the smallest airborne remnant carried
over from the previous PCR procedure or from a strongly
positive sample (contamination), may be multiplied and
produce a false positive results. In the Real-time PCR,
the problem of carry-over is signiﬁcantly reduced because
of the real-time measuring principle, which is based on
closed tube system. In order to increase assay throughput
and minimise operator errors, real-time PCR assays for
FMDV have also been automated using robots for nucleic
acid extraction and liquid handling equipment to setup the
reaction mixes [146, 169]. The assay has also been applied
for FMDV and it is capable of detecting all seven serotypes
[39, 161, 169–177]. First interassay/laboratory equivalence
investigation [178], participated by ﬁve European reference
laboratories for detection of FMDV has observed that the
best of the Real-Time PCR assays used in each laboratory
gave comparable results unlike the VI results which were
highly variable. Performance of three real-time instruments:
the LightCycler.2 (Roche), the SmartCycler I I (Cepheid),
and the SDS 7900HT (AB) was compared for detection of
FMDV and has successfully identiﬁed the FMDV genome
and beta actin mRNA from several sources of infected nasal
a n do ra ls w a b s ,a sw e lla sp r o b a n gs a m p l e s[ 167]. In addition
to extensive testing of vesicular epithelium samples, the
performance of rRT-PCR has recently been assessed on milk
[179] and “probang” samples [180]. Automated real-time
RT-PCR has been compared with VI and antigen-detection
ELISA with result being more positive by real-time PCR
indicating that the real-time PCR has higher sensitivity than
VI for the detection of FMDV in epithelial samples [181].
The development of multicolour real-time PCR cyclers
and “ready-to-use” commercial multiplex real-time PCR
kits has also made it possible to combine several assays
within a single tube. Major advantages of multiplexing
include a reduced sample requirement, which is especially
important when sample material is scarce [182, 183], and
the ability to combine assays with an internal control
system. However, it is important to optimize these assays in
order to limit competitive interactions that may signiﬁcantly
impact upon assay sensitivity. The combined properties
of high sensitivity and speciﬁcity, low contamination risk,
and speed have made real-time PCR technology a highly
attractive alternative to tissue culture- or immunoassay-
based methods for diagnosing many infectious diseases
[184]. Clinical diagnostic applications and the use of real-
time PCRs are growing exponentially, and real-time PCR is
rapidly replacing conventional PCR and other established
diagnostic methods such as antigen-ELISA and cell culture
isolation.
5.7. Recombinant Antigen-Based Diagnosis. The 3AB protein
of FMDV was expressed in E. coli [185–187]o ri nP. pastoris
[188] and has been used for the diagnosis of FMD infection
in cattle. Similarly, 3ABC proteins expressed in heterologous
systems were used in ELISA (3ABC ELISA) for serodiagnosis
of FMD [189, 190]. Further, four serotypes of FMDV
structural proteins expressed in P. pastoris and its potential
utility either as immunogen or antigen has been successfully
assessed in animal model [191–193]. A recombinant FMDV
polyprotein (P1) with 3C expressed in insect cells was
evaluated for detecting antibodies to FMDV serotype Asia 1
in ELISA and has the potential to replace the liquid phase
blocking(LPB)-ELISAusinganinactivatedFMDVantigenas
a simple and robust serological tool for screening antibodies
to FMDV serotype Asia 1 [194].
5.8. DIVA-Based Companion Diagnostic Approach. The abil-
ity to identify and selectively delete genes from a pathogen
hasallowedthedevelopmentof“markervaccines”that,com-
bined with suitable diagnostic assays, allow diﬀerentiating
infected from vaccinated animals (DIVA) by diﬀerentiation
of antibody responses induced by the vaccine (no antibodies
generated to deleted genes) from those induced during
infection with the wild-type virus [195].
A number of antigenic non-structural proteins (NSPs) of
FMD were identiﬁed and out of which 3ABC gene appears
to be the most reliable marker of FMD virus replication
[196, 197]. The deletion of NSP (3ABC) gene has been
used for enabling DIVA approach for FMD (Cedivac-FMD
inactivated vaccine). For detection of NSP antibodies, the
Ceditest FMD-NS ELISA is commercially available. Indirect
ELISA test for the detection of antibodies against non-
structuralproteinswillplayanessentialroleintheserological
survey of livestock herds in future postoutbreak situations.
It has been demonstrated that protection against foot-
and-mouth disease (FMD) could be achieved following
vaccination with chimeric foot-and-mouth disease virus
(FMDV) vaccines, in which the VP1 G-H loop had been
substituted with that from another serotype. This indicated
thattheVP1G-Hloopmaynotbeessentialfortheprotection
of natural hosts against FMDV. If this could be substantiated
there would be potential to develop FMD marker vaccines,
characterised by the absence of this region [198]. A mutant
FMDV with deletion of immunodominant epitopes was
evaluated to use as a marker vaccine recently, In that
study, a B-cell epitope was identiﬁed in the 3A region of
a nonstructural protein (NSP) by anti-FMDV cattle sera
and a recombinant FMDV (rvAs-3A14D) was generated by
selectively deleting 14 amino acids (position 91–104) in the
3A region of the NSP. Following in vitro transcription and
transfection in BHK-21 cells, the rvAs-3A14D was rescued
from BHK-21 cells. Characterization of the rvAs-3A14D
revealed that the infectivity, antigenecity, and replication
kinetics in BHK21 cells and virulence in mice of the rvAs-
3A14D were similar to that of its parent virus. Those data8 Veterinary Medicine International
suggested that the recombinant FMDV with deletion of this
epitope in the NSP may be potentially used as a candidate
inactivated vaccine and therefore, the application of the
marker vaccine and diﬀerential diagnostic tests may open a
promising new avenue for the development of a vaccine for
DIVA.
5.9.Microarray-BasedDiagnosisofFMDV. DNAmicroarrays
are becoming increasingly useful for the analysis of gene
expression and single nucleotide polymorphisms (SNPs)
[199–201]. The application to discriminate among variants
of FMDV is added to a number of microarray procedures
used in virology to analyze multiple viral pathogens that
belong to diﬀerent virus families [202], to detect speciﬁc
viruses [203, 204] or to deﬁne genetic variations undergone
by viruses [205, 206].
The distinction among mutants of the same virus is
becoming increasingly necessary in view of the extensive
variation among representatives of most virus groups [207],
the quasispecies population structure of RNA viruses and
some DNA viruses [208], and the increasing recognition that
one or a limited number of mutations in a viral genome can
have a profound eﬀect in its biological behavior [209, 210].
Baxi et al. [211] developed a microarray-based test that
used a FMD DNA chip containing 155 oligonucleotide
probes, 35–45 base pairs (bp) long, and serotype-speciﬁc,
designed from the VP3,VPl-2A region of the genome. A set
of two forward primers and one reverse primer were also
designed to allow ampliﬁcation of approximately 1100 bp of
target sequences from this region. The ampliﬁed target was
labelled with Alexa-Fluor 546 dye and applied to the FMD
DNA chip. A total of 23 diﬀerent FMDV strains representing
all seven serotypes were detected and typed by the FMD
DNA chip. Microarray technology oﬀers a unique capability
to identify multiple pathogens in a single chip [211].
It was documented that DNA microarray technology can
be used as a high-throughput method to analyze polymor-
phisms within a short region of the FMDV genome and
have successfully devised a SVM-based method to classify
the samples on the basis of their hybridization signal and to
detect SNPs at a major antigenic site of the virus [212].
5.10. Biosensors for Detection of FMDV. An immunobiosen-
sor using a piezo electric (PZ) crystal was developed and
standardized for foot- and- mouth disease (FMD) diagnosis
and virus typing [213]. Allosteric biosensors allow detection
of antibodies against diﬀerent viruses by accommodating
peptide sequences from surface viral proteins, acting as
antibody receptors, into permissive sites of allosterically
responsive recombinant β-galactosidases. Among the advan-
tages of such biosensors as diagnostic tools is the homoge-
neous nature of the assay, the short time required for the
enzymaticreactionandantibodydetection,andthepotential
for handling large number of samples and for automatic
processing, as shown for human immunodeﬁciency virus
[214, 215]. In the serological diagnosis of infectious diseases,
the use of allosteric biosensors, namely, hybrid enzymes
that respond enzymatically to antibodies directed to foreign
peptidesdisplayedontheenzymesurface[216,217],ishighly
promising [218]. Multiple insertions of a major FMDV B-
cell epitope from the VP1 capsid protein near the active
site of recombinant β-galactosidases dramatically increased
theenzymeresponsivenesstospeciﬁcantipeptideantibodies,
including sera from infected animals [219, 220]. It has been
reported that recombinant β-galactosidases accommodating
one or two diﬀerent peptides from the FMDV NS protein
3B per enzyme monomer can be reactivated by anti-3B
monoclonal antibodies (MAbs) and these recombinant β-
galactosidases could be also eﬃciently reactivated by sera
frominfectedanimalsthatpermitteddiﬀerentiation between
sera from infected animals and those from na¨ ıve and con-
ventionally vaccinated pigs. These infection-speciﬁc FMDV
biosensors can provide an eﬀective and versatile alternative
for the serological distinction of FMDV-infected animals
[221].
5.11. Nucleic-Acid-Based Diagnostic Methods. FMDV sero-
types A, O, and C was possible, using cDNA probes from
individual serotypes that corresponded to structural protein
VP1, where thirteen complementary DNA (cDNA) probes
labelled with 32P were used to detect the presence of foot-
and-mouth disease virus (FMDV) enabled the detection of 1
p go fv i r a l - R N A ,o r1v i r u sc o p yp e rc e l l[ 222].
A nucleic acid sequence-based ampliﬁcation (NASBA)
assay for the detection of foot-and-mouth disease virus
(FMDV) was developed. Two detection methods, NAS-
BAelectrochemiluminescence (NASBA-ECL) and a newly
developed NASBA-enzymelinked oligonucleotide capture
(NASBA-EOC), were evaluated and compared with other
laboratory-based methods, data analysis support the use of
NASBA as a rapid and sensitive diagnostic method for the
detection and surveillance of FMDV [223].
5.12. Phage Display-Based Diagnosis. Due to the high anti-
genic variability of FMDV, it is important to undertake
mutation analysis under immunological pressure. To study
the bovine antibody response at a molecular level, phage
display technology was used to produce bovine anti-FMDV
Fabs where CH1-VH chains with FMDV speciﬁc binding
was isolated after selection from a library made from
vaccinated cattle [224]. Recently, screening a phage displayed
random 12-peptide library, it was found that positive phages
displaying the consensus motif ETTXLE (X is any amino
acid (aa)), which is highly homologous to 6ETTLLE11 at
the N-terminus of the VP2 protein (structural protein) of
the FMDV, a minimal epitopic region require to bind a
monoclonal antibody of serotype independent FMDV (MAb
4B2)andthuscanbeusedasauniversaldiagnosticcandidate
against.
5.13. Pen Side Diagnostic Approach. Routine diagnosis of
FMD is made at several laboratories by the combined
use of enzyme-linked immunosorbent assay (ELISA), virus
isolation techniques, supplemented by reverse transcriptase
PCR (RT-PCR), and so forth, which has been already dis-
cussed. However, most of these diagnostic methods require
the availability of a dedicated laboratory facility, highly
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sample handling or preparation, and management of the
logistical considerations associated with sample collection
and transport is also required [122]. A rapid and easy-to-
perform test, which would allow for on-site diagnosis to be
made in the case of a suspected disease outbreak, would
circumvent problems associated with the transportation of
samples to the laboratory and would be especially useful
for a faster diagnosis in areas where the disease is endemic.
Availability of “point of care” or “pen-side” diagnostic tests
would have the advantage of rapid, user friendly, correct
identiﬁcation of a particular strain and economically feasible
diagnosis of FMD in ﬁeld condition. Development of a rapid
chromatographicstriptest,lateralﬂowdevice(LFD)forpen-
side diagnosis based on a monoclonal antibodies that reacts
a g a i n s tF M D Vo fa l ls e v e ns e r o t y p e s[ 170].
The LFA is an appropriate technology on which to base a
rapid assay. The technique permits rapid diagnosis, allowing
time for the early implementation of control measures to
reduce the possibility of spread of FMD. The LFA has been
developed widely to support clinical diagnosis of diﬀerent
diseases [225–227], including FMD [170, 228]. A rapid
lateral-ﬂow assay (LFA) based on FMDV antigen detection,
which is easy to use and can be utilized on the farm to reduce
the time required for transport and laboratory diagnosis.
The detection of FMDV antigens by direct application of
vesicular ﬂuids and epithelial suspensions from animals of
an infected farm may reduce the chances of diagnostic
error arising from nonspeciﬁc reactions. Oem et al. showed
that the diagnostic sensitivity of the LFA for FMDV types
O, A, C, and Asia 1 was similar, at approximately 87.3%,
to that of 87.7% obtained with antigen enzyme-linked
immunosorbent assay (AgELISA). But the speciﬁcity of the
LFA was 98.8%, compared to 100% for the AgELISA [122].
Recently a lateral ﬂow device (LFD) for the detection of foot-
and-mouth disease virus (FMDV) of the SAT 2 serotype
was developed using a monoclonal antibody (Mab 2H6)
for providing rapid and objective support to veterinarians
in their clinical judgment of the disease and for speciﬁc
conﬁrmation of a FMDV type SAT 2 infection [229].
Again a simple, rapid, colloidal gold-based immuno
chromatographic strip tests were developed for easy clinical
testing of serotype A of FMDV in ﬁeld sites was developed
with sensitivity and speciﬁcity 88.7% and 98.7%, respec-
tively [230]. Such pen-side diagnosis would have particular
beneﬁts in FMD emergencies, relevance to FMD control
programmes which operate in endemic regions of the world
such as South East Asia and for increasing disease awareness
in other areas where eﬀorts to control disease may be
diﬃcult [170]. In each circumstance the availability of a
pen-side device for diagnosis would reduce the necessity for
sending routine diagnostic samples to an FMD laboratory
and thereby reduce the delay in diagnosis, which can in some
areas be considerable.
AnalternativemoleculartechniquecalledLoopMediated
Isothermal Ampliﬁcation (LAMP) was developed for detec-
tionofviruses,wheretargetDNAorRNAspeciﬁcallyamplify
using four speciﬁc primers under isothermal conditions
[231,232].AnewversionLAMPcalledReverseTranscription
Loop Mediated Isothermal Ampliﬁcation (RT-LAMP) was
developed for rapid, speciﬁc and sensitive detection of
viruses including FMDV in laboratory and in ﬁeld condition
[233, 234].
6. Conclusion
Foot-and-mouth disease virus (FMDV) is an important
veterinary pathogen which can cause widespread epidemics.
Many works have been carried out to develop and validate
diagnostic tests in regard to the FMD. Conventional tech-
niques to detect FMDV infection are either not precisely
speciﬁc or lack an optimum degree of sensitivity which
cannot be overlooked when screening of a herd is concerned.
With the critical need for improved diagnostic tests to
detect viral infection, eﬀort need to be concentrated on
the development of simple, rapid, noninvasive tests that
can be performed without expensive laboratory equipment.
In this context although various molecular tools are very
promising but to make it a successful tool search for more
rapid and accurate tests as well as an earlier detection system
in preclinical state are needed for the hour.
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